Objective: To investigate whether alterations in the phosphorylation status of matrix metalloproteinase 2 (MMP-2) in the heart may be protective in the setting of ischaemia-reperfusion (IR) injury.
Design: In-vitro heart function and biochemical research study.
Setting: University basic science laboratory.